Injection safety support (INS)
One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI began offering Injection Safety Support (INS) in mid-2001 to countries that wanted to introduce or increase the use of auto-disable (AD) syringes and safety boxes into their national immunisation programmes for vaccines not supported by GAVI. To date, 71 GAVI-eligible countries have received GAVI’s injection safety support (INS), and by the end of 2009 when the INS window closed, 66 countries reported that they were supporting injection safety practices either through donor support or their own health ministry budgets. GAVI's INS support has improved injection safety practices and almost all recipient countries have found ways to replace and sustain the use of AD syringes and safety boxes.
- ID Projet
47122-07-LBR-07A-Z
- Statut de l'activité
- 3 - Completion
- Type d'aide
- B02 - Contributions aux budgets réguliers des institutions multilatérales
- % to Libéria
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
Versements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
2006 |
Q1 |
116,000.00 |
116,000.00 |
Engagements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
2005 |
Q3 |
116,000.00 |
116,000.00 |
Projections de CDMT par exercice fiscal
Exercice fiscal |
Montant (USD) |
Libéria Montant (USD) |
2007 |
58,000.00 |
58,000.00 |
2006 |
58,000.00 |
58,000.00 |
Code CRS |
% |
Soins et services de santé de base
(12220)
|
100.0
|